| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |